Drugs / D4064A
last change Sep 2008 re-read 3 minutes ago

D4064A

Developed for
fallopian tube cancer · ovarian cancer · peritoneum cancer
Investigated by
Genentech, Inc.

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00753480 Sep 2008 → ? fallopian tube cancer, ovarian cancer, peritoneum cancer Genentech, Inc. Suspended No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as D4064A ClinicalTrials.gov intervention name — accepted as the source's own label NCT00753480 ↗
Route Intravenous “administered by IV infusion” NCT00753480 ↗